The state of Texas currently has 40 active clinical trials seeking participants for Asthma research studies. These trials are conducted in various cities, including Houston, Dallas, San Antonio and Austin.
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
Recruiting
This is a randomized clinical trial of metformin among overweight or obese adults with not well-controlled asthma despite maintenance inhaler therapy.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/02/2025
Locations: Baylor College of Medicine, Houston, Texas
Conditions: Asthma, Asthma Chronic, Overweight and Obesity
A Coping Skills Program for Children With Asthma
Recruiting
Uncontrolled asthma in school-aged children is a significant public health problem. Latino children living in low-income contexts are at increased risk for uncontrolled asthma compared to non-Latino white children, and stress is an unaddressed factor in this disparity. Therefore, the purpose of the current study is to test an intervention program that teaches families skills to cope with asthma-related and other sources of stress. Specifically, the study will compare the effects of the combined... Read More
Gender:
ALL
Ages:
8 years and above
Trial Updated:
07/23/2024
Locations: University of Texas at Austin, Austin, Texas
Conditions: Asthma in Children
A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)
Recruiting
This is a two-arm, parallel design, randomized, controlled pilot trial comparing access to Asma Guardián, a culturally tailored multi-component app-based asthma intervention for Hispanic/Latinx school age children with asthma, to usual care.
Gender:
ALL
Ages:
Between 5 years and 12 years
Trial Updated:
06/28/2024
Locations: University of Texas at Austin, Austin, Texas
Conditions: Asthma in Children
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Recruiting
The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compared with FF/VI after 24 weeks of treatment.
Gender:
ALL
Ages:
Between 12 years and 17 years
Trial Updated:
05/24/2024
Locations: GSK Investigational Site, Boerne, Texas +4 locations
Conditions: Asthma